Discontinued — last reported Q4 '22
Business Segments · Restructuring (Note 20)
Consumer — Restructuring (Note 20)
Johnson & Johnson Consumer — Restructuring (Note 20) remained flat by 0.0% to $25.00M in Q4 2022 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $25.00M to $25.00M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2009
Last reportedQ4 2022
Rolls up toRestructuring Charges
How to read this metric
High restructuring costs indicate significant organizational change, which may lead to future margin improvements but signals current operational friction.
Detailed definition
Costs incurred by the Consumer Health segment related to organizational changes, such as workforce reductions or facilit...
Peer comparison
Comparable to restructuring charges or 'special items' reported by peers undergoing corporate transformation.
Metric ID:
jnj_segment_consumer_health_restructuring_note_20Historical Data
2 years
| FY'21 | FY'22 | |
|---|---|---|
| Value | $100.00M | $100.00M |
| YoY Change | — | +0.0% |
Range$100.00M – $100.00M
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's consumer — restructuring (note 20)?
- Johnson & Johnson (JNJ) reported consumer — restructuring (note 20) of $25.00M in Q4 2022.
- How has Johnson & Johnson's consumer — restructuring (note 20) changed year-over-year?
- Johnson & Johnson's consumer — restructuring (note 20) decreased by 0.0% year-over-year, from $25.00M to $25.00M.
- What does consumer — restructuring (note 20) mean?
- One-time costs associated with reorganizing the Consumer Health business to improve efficiency.